Kintor Pharmaceutical Limited (HKG:9939)
Hong Kong
· Delayed Price · Currency is HKD 1.600
-0.090 (-5.33%)
Jun 17, 2025, 4:08 PM HKT
Kintor Pharmaceutical Market Cap
Kintor Pharmaceutical has a market cap or net worth of 733.80 million as of June 17, 2025. Its market cap has increased by 36.89% in one year.
Market Cap
733.80M
Enterprise Value
717.11M
Revenue
5.32M
Ranking
n/a
PE Ratio
n/a
Stock Price
1.60
Market Cap Chart
Since May 22, 2020, Kintor Pharmaceutical's market cap has decreased from 7.94B to 733.80M, a decrease of -90.76%. That is a compound annual growth rate of -37.48%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 16, 2025 | 733.80M | 74.72% |
| Dec 31, 2024 | 419.98M | -42.42% |
| Dec 29, 2023 | 729.42M | -83.45% |
| Dec 30, 2022 | 4.41B | -7.54% |
| Dec 31, 2021 | 4.77B | 23.38% |
| Dec 31, 2020 | 3.86B | -51.35% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeOne Medicines | 269.70B |
| Hansoh Pharmaceutical Group Company | 174.81B |
| Innovent Biologics | 133.28B |
| JD Health International | 130.24B |
| WuXi Biologics | 113.92B |
| CSPC Pharmaceutical Group | 101.03B |
| Sino Biopharmaceutical | 98.90B |
| Akeso | 86.03B |